<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-26572" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Pancreatic Insufficiency</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ghodeif</surname>
            <given-names>Alhassan O.</given-names>
          </name>
          <aff>Sheffield Teaching Hospital</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Azer</surname>
            <given-names>Samy A.</given-names>
          </name>
          <aff>King Saud University, King Khalid UH</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Alhassan Ghodeif declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Samy Azer declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>16</day>
          <month>1</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-26572.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>The pancreas has an essential role in the digestion, absorption, and metabolism of carbohydrates, fats, and proteins. Damage to the cells producing pancreatic enzymes leads to exocrine pancreatic insufficiency, which is a serious problem leading to malnutrition, complications, and poor quality of life. This activity reviews the evaluation and management of the exocrine pancreatic insufficiency and highlights interprofessional team members' role in collaborating to provide well-coordinated care and enhance patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify the etiology of exocrine pancreatic insufficiency.</p></list-item><list-item><p>Outline the appropriate evaluation of exocrine pancreatic insufficiency.</p></list-item><list-item><p>Review the treatment options available for exocrine pancreatic insufficiency.</p></list-item><list-item><p>Describe interprofessional team strategies for improving care coordination and communication to advance exocrine pancreatic insufficiency and improve outcomes.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26572&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26572">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-26572.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The pancreas is a soft, finely lobulated gland located behind the peritoneum on the posterior abdominal wall and has both endocrine and exocrine functions. It plays an essential role in the&#x000a0;digestion,&#x000a0;absorption, and metabolism&#x000a0;of carbohydrates, fats, and proteins.&#x000a0;Exocrine pancreatic&#x000a0;insufficiency (EPI)&#x000a0;refers to reducing pancreatic enzyme activity (mainly pancreatic lipase) in the intestinal lumen below the threshold required for digestive functions. These changes could be due to inadequate pancreatic stimulation of pancreatic secretion, insufficient secretion of pancreatic digestive enzymes by the pancreatic acinar cells, or outflow obstruction of the pancreatic duct, and inadequate mixing of the pancreatic enzymes with food.&#x000a0;&#x000a0;</p>
        <p>Patients with EPI may present with clinical manifestations such as steatorrhea, flatulence, weight loss, and abdominal pain of variable location and severity. The disease is associated with impairment of quality of life, increased risk of complications due to malnutrition and changes in bone density, and increased motility risk. While pancreatic&#x000a0;malfunction&#x000a0;could affect both endocrine and exocrine functions of the pancreas, the term&#x000a0;pancreatic insufficiency&#x000a0;usually refers&#x000a0;to exocrine rather than endocrine deficiency. In this activity, we will focus on exocrine pancreatic insufficiency.</p>
      </sec>
      <sec id="article-26572.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The 2 principal causes of exocrine pancreatic&#x000a0;insufficiency are chronic pancreatitis in adults and cystic fibrosis in children. Other causes include- acute pancreatitis, pancreatic tumors, diabetes mellitus, celiac disease, inflammatory bowel disease, bariatric surgery, human immunodeficiency virus (HIV)/acquired immunodeficiency disease (AIDS), and genetic and congenital causes.<xref ref-type="bibr" rid="article-26572.r1">[1]</xref><xref ref-type="bibr" rid="article-26572.r2">[2]</xref><xref ref-type="bibr" rid="article-26572.r3">[3]</xref>&#x000a0;&#x000a0;</p>
        <p>The Toxic-Metabolic, Idiopathic, Genetic, Autoimmune, Recurrent, and Severe Acute Pancreatitis, Obstructive (TIGAR-O) classification system was developed to categorize causes and risk factors of chronic pancreatitis and pancreatic exocrine insufficiency.<xref ref-type="bibr" rid="article-26572.r4">[4]</xref>&#x000a0;</p>
        <list list-type="bullet">
          <list-item>
            <p>The toxic-metabolic causes include alcohol, tobacco smoking, hypercalcemia, hyperlipidemia, and chronic renal failure.</p>
          </list-item>
          <list-item>
            <p>Idiopathic causes are responsible for approximately 25% of causes, and recently it is related to genetic defects.</p>
          </list-item>
          <list-item>
            <p>The genetic defects may include CFTR mutations, SPINK1 mutations, and hereditary pancreatitis.</p>
          </list-item>
          <list-item>
            <p>The autoimmune causes include pancreatitis associated with Sjogren syndrome, primary biliary cirrhosis, and inflammatory bowel disease.</p>
          </list-item>
          <list-item>
            <p>There is recurrent and severe acute pancreatitis, including recurrent acute pancreatitis, post-necrotic, vascular diseases, and post-radiation.</p>
          </list-item>
          <list-item>
            <p>Obstructive causes include congenital anomalies of pancreatic ducts (large or small ducts), sphincter of Oddi dysfunction, obstruction of the duct by a tumor, and post-traumatic pancreatic duct fibrosis.</p>
          </list-item>
        </list>
        <p>Alcohol excess is a well-recognized cause&#x000a0;of chronic pancreatitis. In the United States, heavy drinkers have a triple risk of developing chronic pancreatitis, and the risk is further increased in drinkers who are also heavy smokers.<xref ref-type="bibr" rid="article-26572.r5">[5]</xref>&#x000a0;The pancreas is one of the primary organs affected by cystic fibrosis.&#x000a0;About 85% of cystic fibrosis patients have EPI, usually acquired soon after birth. All patients, regardless of age, need to be tested for EPI.<xref ref-type="bibr" rid="article-26572.r6">[6]</xref><xref ref-type="bibr" rid="article-26572.r7">[7]</xref>&#x000a0;EPI could present in a small number of patients with celiac disease; however, it usually resolves after dietetic control. EPI should be excluded in patients with celiac disease who remain symptomatic despite a gluten-free diet.<xref ref-type="bibr" rid="article-26572.r2">[2]</xref><xref ref-type="bibr" rid="article-26572.r8">[8]</xref>&#x000a0;</p>
        <p>EPI is not uncommon in inflammatory bowel disease. It could result from disease activity (autoimmune changes) or secondary to medications used in the treatment. Both acute and chronic pancreatitis have increased incidence among inflammatory bowel disease patients.<xref ref-type="bibr" rid="article-26572.r9">[9]</xref><xref ref-type="bibr" rid="article-26572.r10">[10]</xref>&#x000a0;EPI&#x000a0;is&#x000a0;a&#x000a0;well-known&#x000a0;complication after bariatric surgery and could impose an important entity due to the increasing number of such surgeries worldwide.&#x000a0;Altered anatomy and intersecting&#x000a0;symptoms&#x000a0;with the surgery itself&#x000a0;make distinction difficult.&#x000a0;Bariatric surgery&#x000a0;includes&#x000a0;bypassing&#x000a0;a&#x000a0;portion of&#x000a0;the&#x000a0;gastrointestinal&#x000a0;tract; the extent of malabsorption depends&#x000a0;on the length of the part removed.<xref ref-type="bibr" rid="article-26572.r11">[11]</xref>&#x000a0;EPI has been associated with HIV infection and is considered an important cause of chronic diarrhea in patients with HIV. Screening for EPI should be performed in patients with HIV presenting with chronic&#x000a0;diarrhea.<xref ref-type="bibr" rid="article-26572.r12">[12]</xref></p>
      </sec>
      <sec id="article-26572.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The exact prevalence of exocrine pancreatic&#x000a0;insufficiency in the population is unknown. It occurs secondary to multiple causes with varying prevalence.<xref ref-type="bibr" rid="article-26572.r13">[13]</xref>&#x000a0;EPI is prevalent in about 60% to 90% of patients diagnosed with chronic pancreatitis within 10 to 12 years of diagnosis. Chronic pancreatitis occurs in about 42 to 73 per 100,000 of the population in the United States and is considered to be the most common pancreatic disorder associated with pancreatic insufficiency, and this could be compared to 36 to 125 per 100,000 of the population in Japan, China, and India.<xref ref-type="bibr" rid="article-26572.r13">[13]</xref><xref ref-type="bibr" rid="article-26572.r14">[14]</xref><xref ref-type="bibr" rid="article-26572.r15">[15]</xref>&#x000a0;</p>
        <p>A study of the prevalence of EPI in patients admitted with acute pancreatitis found in more than half (62%) of patients, reducing over follow up to 35%. The risk of EPI in those patients was higher when alcohol was the etiology. The risk of EPI was doubled in severe compared to mild acute pancreatitis.<xref ref-type="bibr" rid="article-26572.r16">[16]</xref>&#x000a0;The prevalence of EPI among diabetic patients is low and usually mild to moderate. In a study of 133 patients with diabetes in whom pancreatic insufficiency was evaluated using the&#x000a0;fecal&#x000a0;elastase-1 (FE-1) assay as a screening test, 13% had a low FE-1. Other studies showed that in type 1 diabetes, 10% to 30% had severe and 22% to 56% had a moderate EPI, while in type 2 diabetes, 5% to 46% had EPI.<xref ref-type="bibr" rid="article-26572.r17">[17]</xref><xref ref-type="bibr" rid="article-26572.r18">[18]</xref><xref ref-type="bibr" rid="article-26572.r19">[19]</xref>&#x000a0;About 66% to 92% of patients with advanced pancreatic cancer get EPI. Between 14% and 74% of patients with irritable bowel disease might suffer from EPI.&#x000a0;Among patients undergoing bariatric surgery, the risk of EPI is still high despite enzymatic and nutritional supplements.<xref ref-type="bibr" rid="article-26572.r2">[2]</xref><xref ref-type="bibr" rid="article-26572.r11">[11]</xref>&#x000a0;The prevalence of EPI in patients with HIV/AIDS is estimated to be between 26% to 45%.<xref ref-type="bibr" rid="article-26572.r20">[20]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26572.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Under normal circumstances, when the chyme arrives at the duodenum, both secretin and cholecystokinin are released, leading to the secretion of about 1.5 L/day of pancreatic juice containing pancreatic enzymes (amylase, lipase, and protease), water, and ions (bicarbonate and phosphate). These enzymes are responsible for most of the digestive work in the small intestine.<xref ref-type="bibr" rid="article-26572.r5">[5]</xref>&#x000a0;It is often thought that a loss of 90% of pancreatic function is required before&#x000a0;overt&#x000a0;exocrine insufficiency occurs; however, this is not&#x000a0;well&#x000a0;supported by&#x000a0;current&#x000a0;studies.<xref ref-type="bibr" rid="article-26572.r21">[21]</xref>&#x000a0;Chronic pancreatitis is a condition affecting the pancreas where recurrent inflammation results in a replacement of pancreatic tissue by fibrosis; consequently, both endocrine and exocrine functions of the pancreas could be affected.<xref ref-type="bibr" rid="article-26572.r3">[3]</xref>&#x000a0;There are multiple theories for the pathogenesis of chronic pancreatitis, including toxic metabolic theory, oxidative stress theory, obstructive theory, and necrosis-fibrosis hypothesis.<xref ref-type="bibr" rid="article-26572.r19">[19]</xref><xref ref-type="bibr" rid="article-26572.r22">[22]</xref></p>
        <p>In cystic fibrosis, epithelial cells in pancreatic ducts could be affected by&#x000a0;mutations in the cystic fibrosis transmembrane conductance regulator (<italic toggle="yes">CFTR</italic>) gene that encodes a cAMP-regulated anion channel. Exocrine pancreatic&#x000a0;insufficiency results from chronic obstructive pancreatitis.<xref ref-type="bibr" rid="article-26572.r23">[23]</xref><xref ref-type="bibr" rid="article-26572.r24">[24]</xref>&#x000a0;Also,&#x000a0;decreased ductal bicarbonate secretion and the resulting decreased alkalization of the acinar lumen might enhance inflammation and the destruction of pancreatic ducts.<xref ref-type="bibr" rid="article-26572.r7">[7]</xref>&#x000a0;Diabetes mellitus can lead to EPI. It has been noted that the&#x000a0;pancreas&#x000a0;is smaller in size in patients with type 1 diabetes. This could be secondary to the lack of trophic effect of insulin on acinar cells, autoimmune destruction of islet cells, and reduced pancreatic secretory function due to diabetic neuropathy.<xref ref-type="bibr" rid="article-26572.r25">[25]</xref>&#x000a0;EPI might result from reduced cholecystokinin secretion caused by villous atrophy in celiac disease or milk protein enteropathy patients. Cholecystokinin levels come back to normal after mucosal healing.<xref ref-type="bibr" rid="article-26572.r26">[26]</xref></p>
      </sec>
      <sec id="article-26572.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Pancreatic insufficiency is an important cause of maldigestion and malabsorption.<xref ref-type="bibr" rid="article-26572.r2">[2]</xref>&#x000a0;The combination of steatorrhea and insufficient dietary intake puts patients at significant risk for malnutrition.<xref ref-type="bibr" rid="article-26572.r21">[21]</xref>&#x000a0;It can lead to multiple clinical manifestations, causing poor quality of life and potentially serious complications.<xref ref-type="bibr" rid="article-26572.r13">[13]</xref>&#x000a0;Clinical features of exocrine pancreatic&#x000a0;insufficiency are usually non-specific.&#x000a0;These include&#x000a0;steatorrhea, abdominal discomfort, bloating, and weight loss. Additionally, malnutrition, trace element&#x000a0;and vitamin&#x000a0;deficiency, metabolic bone disease (osteoporosis or osteomalacia), muscle spasms, decreased immune competence, and an increased risk of cardiovascular events frequently occur.<xref ref-type="bibr" rid="article-26572.r27">[27]</xref>&#x000a0;Steatorrhea is the most frequent sign of&#x000a0;EPI; it is recognized when the fat content of stool is more than 7g/day and given that the diet includes 100 g of fat a day. Fat malabsorption requires at least a 5% to 10% fall in pancreatic lipase and trypsin levels.<xref ref-type="bibr" rid="article-26572.r28">[28]</xref>&#x000a0;Following bariatric surgery, patients might present with steatorrhea, weight loss, maldigestion, and malabsorption, which are pathognomonic for EPI and make diagnosis challenging.<xref ref-type="bibr" rid="article-26572.r11">[11]</xref></p>
      </sec>
      <sec id="article-26572.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Exocrine pancreatic insufficiency can be classified into mild, moderate, or severe. Mild insufficiency occurs with reduced secretion of one or two enzymes with preserved bicarbonate and normal fecal fat. Moderate insufficiency includes the above with impaired bicarbonate secretion. Severe insufficiency occurs when all of the above plus steatorrhea.<xref ref-type="bibr" rid="article-26572.r3">[3]</xref>&#x000a0;Exocrine pancreatic&#x000a0;insufficiency can be suspected in patients with suggestive symptoms and clinical history. However, this differs between patients depending on the severity&#x000a0;of insufficiency and its cause. To confirm the diagnosis, laboratory and radiological evaluation would be required.<xref ref-type="bibr" rid="article-26572.r29">[29]</xref>&#x000a0;</p>
        <p>Two categories of tests are recognized: direct and indirect tests. Direct tests such as the&#x000a0;secretin-cholecystokinin stimulation test and endoscopic pancreatic function test. The two tests evaluate the pancreatic secretive function, and while they are sensitive and specific, they are invasive, expensive, and time-consuming, limiting their use in clinical practice.&#x000a0;On the other hand, indirect tests such as fecal, breath, and blood tests assess the implications of EPI. Despite being less sensitive and specific, they are more feasible and less expensive.<xref ref-type="bibr" rid="article-26572.r13">[13]</xref><xref ref-type="bibr" rid="article-26572.r29">[29]</xref>&#x000a0;The gold standard test for diagnosing EPI is the 72-hour fecal fat quantification and determination of the coefficient for fat absorption; however, its use is limited by unacceptance for both patient and laboratory.<xref ref-type="bibr" rid="article-26572.r30">[30]</xref>&#x000a0;</p>
        <p>Fecal elastase-1 (FE-1) is considered a reliable, non-invasive, and less time-consuming test to evaluate EPI. It is not affected by enzyme replacement as well. Such advantages make it a popular test in screening for EPI.<xref ref-type="bibr" rid="article-26572.r31">[31]</xref>&#x000a0;However, it is affected by dilution in watery diarrhea.<xref ref-type="bibr" rid="article-26572.r32">[32]</xref>&#x000a0;An FE-1 of less than 15 mcg/g feces&#x000a0;is&#x000a0;highly sensitive and specific for detecting EPI in patients with chronic pancreatitis; however, intermediate levels (15 to 200 mcg/g feces) are less sensitive and might require using more sensitive tests to confirm the diagnosis. Moreover, FE-1 levels are not reliable in EPI detection in post-pancreatic resection patients.<xref ref-type="bibr" rid="article-26572.r33">[33]</xref>&#x000a0;Fecal chymotrypsin might be of benefit to evaluate compliance with pancreatic enzyme therapy. its value is limited due to intestinal degradation and less availability in laboratories.<xref ref-type="bibr" rid="article-26572.r32">[32]</xref><xref ref-type="bibr" rid="article-26572.r34">[34]</xref></p>
        <p>Serum pancreatic enzymes are not considered a reliable tool to diagnose pancreatic insufficiency. However, only serum trypsinogen could be used as a useful marker for EPI. A serum level below 20 ng per milliliter was sensitive to pancreatic steatorrhea.<xref ref-type="bibr" rid="article-26572.r35">[35]</xref><xref ref-type="bibr" rid="article-26572.r36">[36]</xref>&#x000a0;A replacement for the previously used Secretin-cholecystokinin stimulation test is the endoscopic pancreatic function test (ePFT), which can evaluate pancreatic secretion through quantification of bicarbonate concentration in samples retrieved endoscopically from the duodenum 45 to 60 minutes after intravenous Secretin injection. It is a highly sensitive test and can be used to confirm the diagnosis of EPI in borderline cases.<xref ref-type="bibr" rid="article-26572.r37">[37]</xref>&#x000a0;</p>
        <p>Breath tests measure fat digestion by pancreatic lipase. The test depends on quantifying the recovery rate of 13 CO2 over 6 hours after a meal, which contains 250 mg of 13C-MTG. It can be used to diagnose EPI, but while equally sensitive to fecal elastase, it is not widely available.<xref ref-type="bibr" rid="article-26572.r27">[27]</xref><xref ref-type="bibr" rid="article-26572.r37">[37]</xref>&#x000a0;Testing for nutritional deficiencies such as magnesium, fat-soluble vitamins (A, E, D, and K), and lipoproteins can support the diagnosis of EPI and monitor treatment.<xref ref-type="bibr" rid="article-26572.r29">[29]</xref>&#x000a0;Secretin-stimulated magnetic resonance cholangiopancreatography (S-MRCP) could be considered the most appropriate morphological test for EPI assessment. It could be used as an indicator of pancreatic function. However, it has a low sensitivity (69%) with limited supporting evidence for use in EPI diagnosis.<xref ref-type="bibr" rid="article-26572.r3">[3]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26572.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Treatment for exocrine pancreatic&#x000a0;insufficiency includes&#x000a0;avoiding malnutrition-related complications and improving the patient's quality of life. Documentation of body weight and body mass index along with anthropometric measurements, dual-energy x-ray absorptiometry scan, and screening for nutritional deficiencies (albumin, international normalized ratio, vitamins D, A, and E level, vitamins B and folate) should be performed for all patients diagnosed with EPI at presentation and at least every year to assess the response to replacement therapy and progression of the disease.<xref ref-type="bibr" rid="article-26572.r4">[4]</xref><xref ref-type="bibr" rid="article-26572.r29">[29]</xref><xref ref-type="bibr" rid="article-26572.r37">[37]</xref>&#x000a0;</p>
        <p>Pancreatic enzyme replacement therapy is recommended to treat EPI and resultant malnutrition. it could be enhanced by increasing doses, enteric coating, gastric acid suppression, and proper administration during meals.<xref ref-type="bibr" rid="article-26572.r33">[33]</xref>&#x000a0;There is a need to treat the underlying cause of EPI and lifestyle advice, including abstinence from alcohol, smoking cessation, and dietary modifications in the form of small frequent meals and avoidance of indigestible foods.&#x000a0;Also,&#x000a0;the supplementation of fat-soluble vitamins if required.<xref ref-type="bibr" rid="article-26572.r5">[5]</xref>&#x000a0;</p>
        <p>Pancreatic enzyme replacement therapy (PERT) is the main treatment of EPI. A combination of pancreatic enzymes (lipase, amylase, and protease) prevents malabsorption and restores the normal physiological digestive process. The enteric coating of the enzymatic supplement provides protection from gastric acidity and dissolves afterward in the duodenum in response to alkaline PH. Some patients might require reducing gastric acidity in the case of reduced bicarbonate secretion to dissolve the enteric coat.<xref ref-type="bibr" rid="article-26572.r29">[29]</xref>&#x000a0;</p>
        <p>The dose needed for enzyme replacement differs between patients depending on the severity of the deficiency and individual needs. Moreover, high doses of supplements don't come without complications, so the lowest effective dose should be used. The current recommendation is 25,000&#x000a0;to 40,000 units of lipase taken with meals or half with snacks, then titrated according to response to a maximum of 75,000 to 90,000 units of lipase per meal. In case of poor response, gastric acid suppression and excluding other potential causes for symptoms should be considered.<xref ref-type="bibr" rid="article-26572.r4">[4]</xref><xref ref-type="bibr" rid="article-26572.r29">[29]</xref></p>
        <p>Dietetic management includes advice about keeping a normal diet as possible, along with small frequent meals, avoidance of fat restriction, and very high fiber diets. A referral is recommended to a dietician for a review of dietetic history along with anthropometric measures, plus counseling and support.<xref ref-type="bibr" rid="article-26572.r29">[29]</xref><xref ref-type="bibr" rid="article-26572.r38">[38]</xref>&#x000a0;EPI in cystic fibrosis can be treated by pancreatic enzyme replacement with cautious dosage increments in line with energy consumption.<xref ref-type="bibr" rid="article-26572.r23">[23]</xref>&#x000a0;Evidence suggests that replacement therapy improves survival among pancreatic cancer patients for both operable and non-operable tumors.<xref ref-type="bibr" rid="article-26572.r39">[39]</xref><xref ref-type="bibr" rid="article-26572.r30">[30]</xref>&#x000a0;A promising approach is the use of stem cell technology. It includes pluripotent stem cells to produce pancreatic exocrine cells, but it is still under research.<xref ref-type="bibr" rid="article-26572.r38">[38]</xref>&#x000a0;</p>
      </sec>
      <sec id="article-26572.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Usually, exocrine pancreatic&#x000a0;insufficiency is underdiagnosed due to the broad and non-specific presentation.&#x000a0;Symptoms can easily be confused with functional gastrointestinal disorders.<xref ref-type="bibr" rid="article-26572.r5">[5]</xref><xref ref-type="bibr" rid="article-26572.r29">[29]</xref>&#x000a0;vA&#x000a0;comprehensive approach with the analysis of&#x000a0;history&#x000a0;and investigations is essential to reach an accurate diagnosis. conditions that might be confused with EPI include malabsorption syndromes (such as celiac disease), inflammatory bowel disease, irritable bowel syndrome, microscopic colitis, intestinal bacterial overgrowth, and giardiasis.<xref ref-type="bibr" rid="article-26572.r20">[20]</xref></p>
        <list list-type="bullet">
          <list-item>
            <p>Biliary obstruction</p>
          </list-item>
          <list-item>
            <p>Celiac disease</p>
          </list-item>
          <list-item>
            <p>Giardiasis</p>
          </list-item>
          <list-item>
            <p>Malabsorption syndromes</p>
          </list-item>
          <list-item>
            <p>Inflammatory bowel disease</p>
          </list-item>
          <list-item>
            <p>Intestinal bacterial overgrowth</p>
          </list-item>
          <list-item>
            <p>Irritable bowel syndrome</p>
          </list-item>
          <list-item>
            <p>Microscopic colitis</p>
          </list-item>
          <list-item>
            <p>Zollinger-Ellison syndrome</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26572.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Long-term prognosis depends on proper management and monitoring of pancreatic insufficiency. Patients are at risk of potentially serious complications if not treated properly. The treatment provides a good chance for the relief of symptoms and a better quality of life.</p>
      </sec>
      <sec id="article-26572.s11" sec-type="Complications">
        <title>Complications</title>
        <p>If no treatment is provided for exocrine pancreatic&#x000a0;insufficiency, patients become exposed to complications related to fat malabsorption and malnutrition, reducing the quality of life.&#x000a0;Almost 65% of patients diagnosed with chronic pancreatitis have either osteoporosis or osteopenia. Reduced quality of life due to persistent symptoms, reduced ability to work, and resultant financial troubles. Increased morbidity and mortality due to malnutrition and cardiovascular complications.<xref ref-type="bibr" rid="article-26572.r29">[29]</xref></p>
      </sec>
      <sec id="article-26572.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Prevention comes from preventing causes (such as the proper treatment of acute/chronic pancreatitis) and early intervention to treat complications.&#x000a0;It's important to educate patients about the importance of lifestyle modifications regarding proper diet, abstinence from alcohol, and smoking cessation.&#x000a0;Education should extend to treatment options and the importance of monitoring symptoms and changing doses according to the response.</p>
      </sec>
      <sec id="article-26572.s13" sec-type="Pearls and Other Issues">
        <title>Pearls and Other Issues</title>
        <p>Other important information regarding pancreatic insufficiency follows:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients presenting with mild to moderate EPI may be underestimated or overlooked by general practitioners and clinicians. Early diagnosis and optimization of treatment are critical. &#x000a0;</p>
          </list-item>
          <list-item>
            <p>In&#x000a0;EPI, fat malabsorption often develops before protein and carbohydrate malabsorption because pancreatic lipase has a higher susceptibility to denaturation compared to other enzymes.</p>
          </list-item>
          <list-item>
            <p>The prevalence of EPI is not well known due to differences in the etiologies and hence varying.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>However, the 2 leading causes of EPI are chronic pancreatitis in adults and cystic fibrosis in children, with varying occurrences in patients with diabetes and after bariatric surgery.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Multiple diagnostic tests are usually used to help diagnose EPI; the most popular is fecal elastase-1, being widely available and cost-effective.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The mainstay treatment of EPI is pancreatic enzyme replacement with the need for monitoring and dose adjustments.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>The dose of pancreatic enzyme replacement should be adjusted to the fat content of the meal and administrated with the first bite of a meal and extra by the end of the meal.</p>
          </list-item>
          <list-item>
            <p>There is a vital role in managing EPI for lifestyle modifications (stop smoking and alcohol consumption) and diet control.<xref ref-type="bibr" rid="article-26572.r40">[40]</xref></p>
          </list-item>
          <list-item>
            <p>If EPI is left untreated, malnutrition-related morbidity, poor quality of life, and potentially serious complications, including death, might occur.&#x000a0;</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-26572.s14" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Patients with exocrine pancreatic&#x000a0;insufficiency usually present to their general practitioner with non-specific symptoms. Diagnosis requires a high index of suspicion with a careful medical history, clinical examination, and early intervention for borderline patients. Management of this condition requires an interprofessional team approach to care. This interprofessional team will include clinicians, mid-level practitioners, nurses, and pharmacists. and is shown to improve patient outcomes. The pharmacist has to educate patients with EPI about the importance of compliance with enzyme replacement therapy. The proper use of medications as administration and doses might affect response significantly and management outcomes.&#x000a0;Nurses can educate patients about the nature of the disease, complications, and potential sources of&#x000a0;information. Meanwhile, nurses can help with monitoring the response to treatment and the need for further interventions. The&#x000a0;interprofessional team approach should also include dietician support and specialist advice according to etiology; for example, EPI associated with cystic fibrosis or diabetes mellitus.</p>
      </sec>
      <sec id="article-26572.s15">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=26572&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=26572">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/health/pancreatic-insufficiency/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=26572">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/26572/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=26572">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-26572.s16">
        <title>References</title>
        <ref id="article-26572.r1">
          <label>1</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Benjamin</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Lappin</surname>
                <given-names>SL</given-names>
              </name>
            </person-group>
            <chapter-title>Chronic Pancreatitis</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>6</month>
            <day>21</day>
            <pub-id pub-id-type="pmid">29493950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Haupt</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Geller</surname>
                <given-names>DE</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Quintana Diez</surname>
                <given-names>PM</given-names>
              </name>
            </person-group>
            <article-title>Less common etiologies of exocrine pancreatic insufficiency.</article-title>
            <source>World J Gastroenterol</source>
            <year>2017</year>
            <month>Oct</month>
            <day>21</day>
            <volume>23</volume>
            <issue>39</issue>
            <fpage>7059</fpage>
            <page-range>7059-7076</page-range>
            <pub-id pub-id-type="pmid">29093615</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>L&#x000f6;hr</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Dominguez-Munoz</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rosendahl</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Besselink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mayerle</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lerch</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Akisik</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Kartalis</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Iglesias-Garcia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Boermeester</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dumonceau</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Fockens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Drewes</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Ceyhan</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Lindkvist</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Drenth</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Ewald</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Hardt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>de Madaria</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Witt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schneider</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Manfredi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Br&#x000f8;ndum</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Rudolf</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bollen</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>M</given-names>
              </name>
              <collab>HaPanEU/UEG Working Group</collab>
            </person-group>
            <article-title>United European Gastroenterology evidence-based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPanEU).</article-title>
            <source>United European Gastroenterol J</source>
            <year>2017</year>
            <month>Mar</month>
            <volume>5</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <page-range>153-199</page-range>
            <pub-id pub-id-type="pmid">28344786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pham</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Forsmark</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Chronic pancreatitis: review and update of etiology, risk factors, and management.</article-title>
            <source>F1000Res</source>
            <year>2018</year>
            <volume>7</volume>
            <pub-id pub-id-type="pmid">29946424</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alkaade</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vareedayah</surname>
                <given-names>AA</given-names>
              </name>
            </person-group>
            <article-title>A primer on exocrine pancreatic insufficiency, fat malabsorption, and fatty acid abnormalities.</article-title>
            <source>Am J Manag Care</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>23</volume>
            <issue>12 Suppl</issue>
            <fpage>S203</fpage>
            <page-range>S203-S209</page-range>
            <pub-id pub-id-type="pmid">28727474</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Schwarzenberg</surname>
                <given-names>SJ</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic insufficiency in Cystic Fibrosis.</article-title>
            <source>J Cyst Fibros</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>16 Suppl 2</volume>
            <fpage>S70</fpage>
            <page-range>S70-S78</page-range>
            <pub-id pub-id-type="pmid">28986019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ooi</surname>
                <given-names>CY</given-names>
              </name>
              <name>
                <surname>Durie</surname>
                <given-names>PR</given-names>
              </name>
            </person-group>
            <article-title>Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.</article-title>
            <source>J Cyst Fibros</source>
            <year>2012</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>5</issue>
            <fpage>355</fpage>
            <page-range>355-62</page-range>
            <pub-id pub-id-type="pmid">22658665</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vujasinovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tepes</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Volfand</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rudolf</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Exocrine pancreatic insufficiency, MRI of the pancreas and serum nutritional markers in patients with coeliac disease.</article-title>
            <source>Postgrad Med J</source>
            <year>2015</year>
            <month>Sep</month>
            <volume>91</volume>
            <issue>1079</issue>
            <fpage>497</fpage>
            <page-range>497-500</page-range>
            <pub-id pub-id-type="pmid">26253920</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fousekis</surname>
                <given-names>FS</given-names>
              </name>
              <name>
                <surname>Theopistos</surname>
                <given-names>VI</given-names>
              </name>
              <name>
                <surname>Katsanos</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Christodoulou</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic Involvement in Inflammatory Bowel Disease: A Review.</article-title>
            <source>J Clin Med Res</source>
            <year>2018</year>
            <month>Oct</month>
            <volume>10</volume>
            <issue>10</issue>
            <fpage>743</fpage>
            <page-range>743-751</page-range>
            <pub-id pub-id-type="pmid">30214645</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Antonini</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pezzilli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Angelelli</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Macarri</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic disorders in inflammatory bowel disease.</article-title>
            <source>World J Gastrointest Pathophysiol</source>
            <year>2016</year>
            <month>Aug</month>
            <day>15</day>
            <volume>7</volume>
            <issue>3</issue>
            <fpage>276</fpage>
            <page-range>276-82</page-range>
            <pub-id pub-id-type="pmid">27574565</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vujasinovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Thorell</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rutkowski</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Haas</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Arnelo</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>L&#x000f6;hr</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic Exocrine Insufficiency after Bariatric Surgery.</article-title>
            <source>Nutrients</source>
            <year>2017</year>
            <month>Nov</month>
            <day>13</day>
            <volume>9</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">29137169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Martin</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Scourfield</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rockwood</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>NK</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gazzard</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic insufficiency in patients with HIV infection: role of didanosine questioned.</article-title>
            <source>HIV Med</source>
            <year>2013</year>
            <month>Mar</month>
            <volume>14</volume>
            <issue>3</issue>
            <fpage>161</fpage>
            <page-range>161-6</page-range>
            <pub-id pub-id-type="pmid">22994793</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Capurso</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Traini</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Piciucchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Signoretti</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Arcidiacono</surname>
                <given-names>PG</given-names>
              </name>
            </person-group>
            <article-title>Exocrine pancreatic insufficiency: prevalence, diagnosis, and management.</article-title>
            <source>Clin Exp Gastroenterol</source>
            <year>2019</year>
            <volume>12</volume>
            <fpage>129</fpage>
            <page-range>129-139</page-range>
            <pub-id pub-id-type="pmid">30962702</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Machicado</surname>
                <given-names>JD</given-names>
              </name>
              <name>
                <surname>Chari</surname>
                <given-names>ST</given-names>
              </name>
              <name>
                <surname>Timmons</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Tang</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>A population-based evaluation of the natural history of chronic pancreatitis.</article-title>
            <source>Pancreatology</source>
            <year>2018</year>
            <month>Jan</month>
            <volume>18</volume>
            <issue>1</issue>
            <fpage>39</fpage>
            <page-range>39-45</page-range>
            <pub-id pub-id-type="pmid">29221631</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Singh</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Garg</surname>
                <given-names>PK</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and Management of Chronic Pancreatitis: A Review.</article-title>
            <source>JAMA</source>
            <year>2019</year>
            <month>Dec</month>
            <day>24</day>
            <volume>322</volume>
            <issue>24</issue>
            <fpage>2422</fpage>
            <page-range>2422-2434</page-range>
            <pub-id pub-id-type="pmid">31860051</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>de la Iglesia-Garc&#x000ed;a</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Baston-Rey</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Calvi&#x000f1;o-Suarez</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Lari&#x000f1;o-Noia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Iglesias-Garcia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shi</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Deng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Moore</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>VK</given-names>
              </name>
              <name>
                <surname>Xia</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Windsor</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Dom&#x000ed;nguez-Mu&#x000f1;oz</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Exocrine Pancreatic Insufficiency Following Acute Pancreatitis: Systematic Review and Meta-Analysis.</article-title>
            <source>Dig Dis Sci</source>
            <year>2019</year>
            <month>Jul</month>
            <volume>64</volume>
            <issue>7</issue>
            <fpage>1985</fpage>
            <page-range>1985-2005</page-range>
            <pub-id pub-id-type="pmid">31161524</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>S&#x000f8;fteland</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Poulsen</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Starup-Linde</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Christensen</surname>
                <given-names>TT</given-names>
              </name>
              <name>
                <surname>Olesen</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Singh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Vestergaard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Drewes</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Dimcevski</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic exocrine insufficiency in diabetes mellitus - prevalence and characteristics.</article-title>
            <source>Eur J Intern Med</source>
            <year>2019</year>
            <month>Oct</month>
            <volume>68</volume>
            <fpage>18</fpage>
            <page-range>18-22</page-range>
            <pub-id pub-id-type="pmid">31402275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Weitgasser</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Abrahamian</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Clodi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zlamal-Fortunat</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Hammer</surname>
                <given-names>HF</given-names>
              </name>
            </person-group>
            <article-title>[Exocrine pancreatic insufficiency and diabetes mellitus].</article-title>
            <source>Wien Klin Wochenschr</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>128 Suppl 2</volume>
            <fpage>S163</fpage>
            <page-range>S163-6</page-range>
            <pub-id pub-id-type="pmid">27052236</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexandre-Heymann</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lemoine</surname>
                <given-names>AY</given-names>
              </name>
              <name>
                <surname>Nakib</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kapel</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Ledoux</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Larger</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Nutritional markers in patients with diabetes and pancreatic exocrine failure.</article-title>
            <source>Acta Diabetol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>56</volume>
            <issue>6</issue>
            <fpage>651</fpage>
            <page-range>651-658</page-range>
            <pub-id pub-id-type="pmid">30740639</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Othman</surname>
                <given-names>MO</given-names>
              </name>
              <name>
                <surname>Harb</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Barkin</surname>
                <given-names>JA</given-names>
              </name>
            </person-group>
            <article-title>Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician.</article-title>
            <source>Int J Clin Pract</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>72</volume>
            <issue>2</issue>
            <pub-id pub-id-type="pmid">29405509</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duggan</surname>
                <given-names>SN</given-names>
              </name>
            </person-group>
            <article-title>Negotiating the complexities of exocrine and endocrine dysfunction in chronic pancreatitis.</article-title>
            <source>Proc Nutr Soc</source>
            <year>2017</year>
            <month>Nov</month>
            <volume>76</volume>
            <issue>4</issue>
            <fpage>484</fpage>
            <page-range>484-494</page-range>
            <pub-id pub-id-type="pmid">28735575</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Stevens</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Conwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Zuccaro</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Pathogenesis of chronic pancreatitis: an evidence-based review of past theories and recent developments.</article-title>
            <source>Am J Gastroenterol</source>
            <year>2004</year>
            <month>Nov</month>
            <volume>99</volume>
            <issue>11</issue>
            <fpage>2256</fpage>
            <page-range>2256-70</page-range>
            <pub-id pub-id-type="pmid">15555009</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elborn</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>Cystic fibrosis.</article-title>
            <source>Lancet</source>
            <year>2016</year>
            <month>Nov</month>
            <day>19</day>
            <volume>388</volume>
            <issue>10059</issue>
            <fpage>2519</fpage>
            <page-range>2519-2531</page-range>
            <pub-id pub-id-type="pmid">27140670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Cooney</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>McCray</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Sinn</surname>
                <given-names>PL</given-names>
              </name>
            </person-group>
            <article-title>Cystic Fibrosis Gene Therapy: Looking Back, Looking Forward.</article-title>
            <source>Genes (Basel)</source>
            <year>2018</year>
            <month>Nov</month>
            <day>07</day>
            <volume>9</volume>
            <issue>11</issue>
            <pub-id pub-id-type="pmid">30405068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Struyvenberg</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Martin</surname>
                <given-names>CR</given-names>
              </name>
              <name>
                <surname>Freedman</surname>
                <given-names>SD</given-names>
              </name>
            </person-group>
            <article-title>Practical guide to exocrine pancreatic insufficiency - Breaking the myths.</article-title>
            <source>BMC Med</source>
            <year>2017</year>
            <month>Feb</month>
            <day>10</day>
            <volume>15</volume>
            <issue>1</issue>
            <fpage>29</fpage>
            <pub-id pub-id-type="pmid">28183317</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nousia-Arvanitakis</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Fotoulaki</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Tendzidou</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Vassilaki</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Agguridaki</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Karamouzis</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Subclinical exocrine pancreatic dysfunction resulting from decreased cholecystokinin secretion in the presence of intestinal villous atrophy.</article-title>
            <source>J Pediatr Gastroenterol Nutr</source>
            <year>2006</year>
            <month>Sep</month>
            <volume>43</volume>
            <issue>3</issue>
            <fpage>307</fpage>
            <page-range>307-12</page-range>
            <pub-id pub-id-type="pmid">16954951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perbtani</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Forsmark</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Update on the diagnosis and management of exocrine pancreatic insufficiency.</article-title>
            <source>F1000Res</source>
            <year>2019</year>
            <volume>8</volume>
            <pub-id pub-id-type="pmid">31824646</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vujasinovic</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Valente</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Del Chiaro</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Permert</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>L&#x000f6;hr</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Pancreatic Exocrine Insufficiency in Pancreatic Cancer.</article-title>
            <source>Nutrients</source>
            <year>2017</year>
            <month>Feb</month>
            <day>23</day>
            <volume>9</volume>
            <issue>3</issue>
            <pub-id pub-id-type="pmid">28241470</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nikfarjam</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>RC</given-names>
              </name>
              <collab>Australasian Pancreatic Club Pancreatic Enzyme Replacement Therapy Guidelines Working Group</collab>
            </person-group>
            <article-title>Diagnosis and management of pancreatic exocrine insufficiency.</article-title>
            <source>Med J Aust</source>
            <year>2017</year>
            <month>Aug</month>
            <day>21</day>
            <volume>207</volume>
            <issue>4</issue>
            <fpage>161</fpage>
            <page-range>161-165</page-range>
            <pub-id pub-id-type="pmid">28814218</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lindkvist</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of pancreatic exocrine insufficiency.</article-title>
            <source>World J Gastroenterol</source>
            <year>2013</year>
            <month>Nov</month>
            <day>14</day>
            <volume>19</volume>
            <issue>42</issue>
            <fpage>7258</fpage>
            <page-range>7258-66</page-range>
            <pub-id pub-id-type="pmid">24259956</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dom&#x000ed;nguez-Mu&#x000f1;oz</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>D Hardt</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Lerch</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>L&#x000f6;hr</surname>
                <given-names>MJ</given-names>
              </name>
            </person-group>
            <article-title>Potential for Screening for Pancreatic Exocrine Insufficiency Using the Fecal Elastase-1 Test.</article-title>
            <source>Dig Dis Sci</source>
            <year>2017</year>
            <month>May</month>
            <volume>62</volume>
            <issue>5</issue>
            <fpage>1119</fpage>
            <page-range>1119-1130</page-range>
            <pub-id pub-id-type="pmid">28315028</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brydon</surname>
                <given-names>WG</given-names>
              </name>
              <name>
                <surname>Kingstone</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Ghosh</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Limitations of faecal elastase-1 and chymotrypsin as tests of exocrine pancreatic disease in adults.</article-title>
            <source>Ann Clin Biochem</source>
            <year>2004</year>
            <month>Jan</month>
            <volume>41</volume>
            <issue>Pt 1</issue>
            <fpage>78</fpage>
            <page-range>78-81</page-range>
            <pub-id pub-id-type="pmid">14713391</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de la Iglesia-Garc&#x000ed;a</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Szatmary</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Baston-Rey</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Gonzalez-Lopez</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Prada-Ramallal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mukherjee</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Nunes</surname>
                <given-names>QM</given-names>
              </name>
              <name>
                <surname>Dom&#x000ed;nguez-Mu&#x000f1;oz</surname>
                <given-names>JE</given-names>
              </name>
              <name>
                <surname>Sutton</surname>
                <given-names>R</given-names>
              </name>
              <collab>NIHR Pancreas Biomedical Research Unit Patient Advisory Group</collab>
            </person-group>
            <article-title>Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.</article-title>
            <source>Gut</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>66</volume>
            <issue>8</issue>
            <fpage>1354</fpage>
            <page-range>1354-1355</page-range>
            <pub-id pub-id-type="pmid">27941156</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Conwell</surname>
                <given-names>DL</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>LS</given-names>
              </name>
              <name>
                <surname>Yadav</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Longnecker</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>FH</given-names>
              </name>
              <name>
                <surname>Mortele</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Levy</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Kwon</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lieb</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Stevens</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Toskes</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Gardner</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Gelrud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>BU</given-names>
              </name>
              <name>
                <surname>Forsmark</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Vege</surname>
                <given-names>SS</given-names>
              </name>
            </person-group>
            <article-title>American Pancreatic Association Practice Guidelines in Chronic Pancreatitis: evidence-based report on diagnostic guidelines.</article-title>
            <source>Pancreas</source>
            <year>2014</year>
            <month>Nov</month>
            <volume>43</volume>
            <issue>8</issue>
            <fpage>1143</fpage>
            <page-range>1143-62</page-range>
            <pub-id pub-id-type="pmid">25333398</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pezzilli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Talamini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Gullo</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Behaviour of serum pancreatic enzymes in chronic pancreatitis.</article-title>
            <source>Dig Liver Dis</source>
            <year>2000</year>
            <month>Apr</month>
            <volume>32</volume>
            <issue>3</issue>
            <fpage>233</fpage>
            <page-range>233-7</page-range>
            <pub-id pub-id-type="pmid">10975774</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jacobson</surname>
                <given-names>DG</given-names>
              </name>
              <name>
                <surname>Curington</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Connery</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Toskes</surname>
                <given-names>PP</given-names>
              </name>
            </person-group>
            <article-title>Trypsin-like immunoreactivity as a test for pancreatic insufficiency.</article-title>
            <source>N Engl J Med</source>
            <year>1984</year>
            <month>May</month>
            <day>17</day>
            <volume>310</volume>
            <issue>20</issue>
            <fpage>1307</fpage>
            <page-range>1307-9</page-range>
            <pub-id pub-id-type="pmid">6717495</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dominguez-Mu&#x000f1;oz</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Diagnosis and treatment of pancreatic exocrine insufficiency.</article-title>
            <source>Curr Opin Gastroenterol</source>
            <year>2018</year>
            <month>Sep</month>
            <volume>34</volume>
            <issue>5</issue>
            <fpage>349</fpage>
            <page-range>349-354</page-range>
            <pub-id pub-id-type="pmid">29889111</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dominguez-Mu&#x000f1;oz</surname>
                <given-names>JE</given-names>
              </name>
            </person-group>
            <article-title>Management of pancreatic exocrine insufficiency.</article-title>
            <source>Curr Opin Gastroenterol</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>5</issue>
            <fpage>455</fpage>
            <page-range>455-459</page-range>
            <pub-id pub-id-type="pmid">31219829</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r39">
          <label>39</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Roberts</surname>
                <given-names>KJ</given-names>
              </name>
              <name>
                <surname>Bannister</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Schrem</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Enzyme replacement improves survival among patients with pancreatic cancer: Results of a population based study.</article-title>
            <source>Pancreatology</source>
            <year>2019</year>
            <month>Jan</month>
            <volume>19</volume>
            <issue>1</issue>
            <fpage>114</fpage>
            <page-range>114-121</page-range>
            <pub-id pub-id-type="pmid">30385188</pub-id>
          </element-citation>
        </ref>
        <ref id="article-26572.r40">
          <label>40</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Pongprasobchai</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Maldigestion from pancreatic exocrine insufficiency.</article-title>
            <source>J Gastroenterol Hepatol</source>
            <year>2013</year>
            <month>Dec</month>
            <volume>28 Suppl 4</volume>
            <fpage>99</fpage>
            <page-range>99-102</page-range>
            <pub-id pub-id-type="pmid">24251713</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
